FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2293996237> ?p ?o ?g. }

• W2293996237 endingPage "5027" @default.
• W2293996237 startingPage "5018" @default.
• W2293996237 abstract "This study evaluated the effects of oral meloxicam administration on metabolic, inflammatory, and acute-phase responses of beef cattle receiving a lipopolysaccharide (LPS) challenge (Exp. 1; d -1 to 6) or vaccinated against respiratory pathogens (Exp. 2; d 7 to 21). Twenty-one Angus steers ( = 11) and heifers ( = 10) were housed in individual pens on d -15 and were offered free-choice water, mineral-vitamin mix, and hay until d 21. In Exp. 1, cattle were ranked on d -1 by sex and BW and assigned to 1) oral meloxicam administration (1 mg/kg BW daily) from day -1 to 6 (MEL8), 2) oral meloxicam administration (1 mg/kg BW) on d 0 and oral lactose monohydrate administration (1 mg/kg BW) on d -1 and from d 1 to 6 (MEL1), or 3) oral lactose monohydrate administration (1 mg/kg BW daily) from d -1 to 6 (CON). On d 0, cattle received an intravenous LPS bolus (0.5 μg/kg BW) concurrently with treatment administration. Rectal temperature (RTEMP) was assessed, and blood samples were collected at -2, 0, 2, 4, 6, 8, 12, 16, 24, 36, 48, 60, 72, 96, 120, and 144 h relative to LPS administration. No treatment effects were detected ( ≥ 0.36) for RTEMP, concentrations of serum tumor necrosis factor α (TNFα), plasma haptoglobin, cortisol, insulin, and leptin, as well as blood mRNA expression of α and cyclooxygenase-2, although all variables increased ( < 0.01) across treatments after LPS administration. In Exp. 2, cattle received the same treatments that they were assigned to in Exp. 1 from d 7 to d 13 and were vaccinated against respiratory pathogens concurrently with treatment administration on d 8. Blood samples were collected, and RTEMP was assessed as in Exp. 1 in addition to 168, 240, and 336 h relative to vaccination. No treatment effects were detected ( ≥ 0.26) for RTEMP, the same plasma and serum variables evaluated in Exp. 1, and serum concentrations of antibodies against or serum titers against bovine respiratory syncytial virus, bovine herpesvirus-1, bovine viral diarrhea virus-1, and parainfluenza-3 virus. All variables increased ( < 0.01) across treatments after vaccination, except for serum TNFα and titers against bovine viral diarrhea virus-1 ( ≥ 0.40). Collectively, this study found no evidence that oral meloxicam administration, at the doses and intervals utilized herein, mitigated the metabolic, inflammatory, and acute-phase reactions elicited by LPS administration or vaccination against respiratory pathogens." @default.
• W2293996237 created "2016-06-24" @default.
• W2293996237 creator A5004032529 @default.
• W2293996237 creator A5016525939 @default.
• W2293996237 creator A5033726402 @default.
• W2293996237 creator A5039799699 @default.
• W2293996237 creator A5052718849 @default.
• W2293996237 creator A5066128009 @default.
• W2293996237 date "2015-10-01" @default.
• W2293996237 modified "2023-10-02" @default.
• W2293996237 title "Effects of oral meloxicam administration to beef cattle receiving lipopolysaccharide administration or vaccination against respiratory pathogens1" @default.
• W2293996237 cites W1965569757 @default.
• W2293996237 cites W1970929172 @default.
• W2293996237 cites W1971971926 @default.
• W2293996237 cites W1975856443 @default.
• W2293996237 cites W1997087247 @default.
• W2293996237 cites W1997626690 @default.
• W2293996237 cites W2002596419 @default.
• W2293996237 cites W2005102922 @default.
• W2293996237 cites W2005145329 @default.
• W2293996237 cites W2010261839 @default.
• W2293996237 cites W2015847388 @default.
• W2293996237 cites W2016759602 @default.
• W2293996237 cites W2018025125 @default.
• W2293996237 cites W2023760490 @default.
• W2293996237 cites W2025861036 @default.
• W2293996237 cites W2028776576 @default.
• W2293996237 cites W2030615798 @default.
• W2293996237 cites W2035346951 @default.
• W2293996237 cites W2044798581 @default.
• W2293996237 cites W2045247536 @default.
• W2293996237 cites W2049352926 @default.
• W2293996237 cites W2052053283 @default.
• W2293996237 cites W2055472228 @default.
• W2293996237 cites W2060780414 @default.
• W2293996237 cites W2083023359 @default.
• W2293996237 cites W2083318804 @default.
• W2293996237 cites W2085519902 @default.
• W2293996237 cites W2092616812 @default.
• W2293996237 cites W2106866486 @default.
• W2293996237 cites W2114928681 @default.
• W2293996237 cites W2125899391 @default.
• W2293996237 cites W2144887013 @default.
• W2293996237 cites W2154273881 @default.
• W2293996237 cites W2154502881 @default.
• W2293996237 cites W2297040872 @default.
• W2293996237 cites W2412025100 @default.
• W2293996237 cites W2419500568 @default.
• W2293996237 cites W266330480 @default.
• W2293996237 doi "https://doi.org/10.2527/jas.2015-9424" @default.
• W2293996237 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26523594" @default.
• W2293996237 hasPublicationYear "2015" @default.
• W2293996237 type Work @default.
• W2293996237 sameAs 2293996237 @default.
• W2293996237 citedByCount "17" @default.
• W2293996237 countsByYear W22939962372016 @default.
• W2293996237 countsByYear W22939962372017 @default.
• W2293996237 countsByYear W22939962372018 @default.
• W2293996237 countsByYear W22939962372019 @default.
• W2293996237 countsByYear W22939962372020 @default.
• W2293996237 countsByYear W22939962372021 @default.
• W2293996237 countsByYear W22939962372022 @default.
• W2293996237 countsByYear W22939962372023 @default.
• W2293996237 crossrefType "journal-article" @default.
• W2293996237 hasAuthorship W2293996237A5004032529 @default.
• W2293996237 hasAuthorship W2293996237A5016525939 @default.
• W2293996237 hasAuthorship W2293996237A5033726402 @default.
• W2293996237 hasAuthorship W2293996237A5039799699 @default.
• W2293996237 hasAuthorship W2293996237A5052718849 @default.
• W2293996237 hasAuthorship W2293996237A5066128009 @default.
• W2293996237 hasBestOaLocation W22939962371 @default.
• W2293996237 hasConcept C126322002 @default.
• W2293996237 hasConcept C134018914 @default.
• W2293996237 hasConcept C140793950 @default.
• W2293996237 hasConcept C206396517 @default.
• W2293996237 hasConcept C2777056448 @default.
• W2293996237 hasConcept C2778754761 @default.
• W2293996237 hasConcept C2779751750 @default.
• W2293996237 hasConcept C71924100 @default.
• W2293996237 hasConcept C86803240 @default.
• W2293996237 hasConceptScore W2293996237C126322002 @default.
• W2293996237 hasConceptScore W2293996237C134018914 @default.
• W2293996237 hasConceptScore W2293996237C140793950 @default.
• W2293996237 hasConceptScore W2293996237C206396517 @default.
• W2293996237 hasConceptScore W2293996237C2777056448 @default.
• W2293996237 hasConceptScore W2293996237C2778754761 @default.
• W2293996237 hasConceptScore W2293996237C2779751750 @default.
• W2293996237 hasConceptScore W2293996237C71924100 @default.
• W2293996237 hasConceptScore W2293996237C86803240 @default.
• W2293996237 hasFunder F4320306114 @default.
• W2293996237 hasIssue "10" @default.
• W2293996237 hasLocation W22939962371 @default.
• W2293996237 hasLocation W22939962372 @default.
• W2293996237 hasLocation W22939962373 @default.
• W2293996237 hasOpenAccess W2293996237 @default.
• W2293996237 hasPrimaryLocation W22939962371 @default.
• W2293996237 hasRelatedWork W1976766119 @default.
• W2293996237 hasRelatedWork W2026386038 @default.

• next